Stallergenes Greer production back to full capacity after years of limited activity

An IT breakdown in 2015 has been the thorn in the side of Stallergenes Greer, which has only now regained full production capacity as it re-launches its series of allergy vaccines in Spain and Italy.
Photo: Stallergenes Greer/PR
Photo: Stallergenes Greer/PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT

French allergy firm Stallergenes Greer is finally back on track with production at its facilities in Southern Paris, it reports in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading